Comprehensive Analysis of the Role of SLC2A3 on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma

Background. SLC2A3 is upregulated in various cancer types and promotes proliferation, invasion, and metabolism. However, its role in the prognosis and immune regulation of head and neck squamous cell carcinoma (HNSCC) is still obscure. This study is aimed at exploring the prognostic and immunotherap...

Full description

Saved in:
Bibliographic Details
Main Authors: Manru Chu, Ke Zheng, Xiaojie Li, Zhiqiang Luo, Xin Yang, Changbo Wei
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2022/2371057
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563476332019712
author Manru Chu
Ke Zheng
Xiaojie Li
Zhiqiang Luo
Xin Yang
Changbo Wei
author_facet Manru Chu
Ke Zheng
Xiaojie Li
Zhiqiang Luo
Xin Yang
Changbo Wei
author_sort Manru Chu
collection DOAJ
description Background. SLC2A3 is upregulated in various cancer types and promotes proliferation, invasion, and metabolism. However, its role in the prognosis and immune regulation of head and neck squamous cell carcinoma (HNSCC) is still obscure. This study is aimed at exploring the prognostic and immunotherapeutic potential of SLC2A3 in HNSCC. Methods. All data were downloaded from TCGA database and integrated via R software. SLC2A3 expression was evaluated using R software, TIMER, CPTAC, and HPA databases. The association between SLC2A3 expression and clinicopathologic characteristics was assessed by R software. The effect of SLC2A3 on survival was analyzed by R software and Kaplan-Meier Plotter. Genomic alterations in SLC2A3 were investigated using the cBioPortal database. Coexpression of SLC2A3 was studied using LinkedOmics and STRING, and enrichment analyses were performed with R software. The relationship between SLC2A3 expression and immune infiltration was determined using TIMER and TISIDB databases. Immune checkpoints and ESTIMATE score were analyzed via the SangerBox database. Results. SLC2A3 expression was upregulated in HNSCC tissues compared to normal tissues. It was significantly related to TNM stage, histological grade, and alcohol history. High SLC2A3 expression was associated with poor prognosis in HNSCC. Coexpression analysis indicated that SLC2A3 mostly participated in the HIF-1 signaling pathway and glycolysis. Furthermore, SLC2A3 expression strongly correlated with tumor-infiltrating lymphocytes in HNSCC. Conclusion. SLC2A3 could serve as a potential prognostic biomarker for tumor immune infiltration in HNSCC.
format Article
id doaj-art-1d298035e5c94ec8bea3328384412aa4
institution Kabale University
issn 2210-7185
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-1d298035e5c94ec8bea3328384412aa42025-02-03T01:20:06ZengWileyAnalytical Cellular Pathology2210-71852022-01-01202210.1155/2022/2371057Comprehensive Analysis of the Role of SLC2A3 on Prognosis and Immune Infiltration in Head and Neck Squamous Cell CarcinomaManru Chu0Ke Zheng1Xiaojie Li2Zhiqiang Luo3Xin Yang4Changbo Wei5Suzhou Stomatological HospitalDepartment of StomatologySuzhou Stomatological HospitalSuzhou Stomatological HospitalGenetics and Cellular Engineering GroupSuzhou Stomatological HospitalBackground. SLC2A3 is upregulated in various cancer types and promotes proliferation, invasion, and metabolism. However, its role in the prognosis and immune regulation of head and neck squamous cell carcinoma (HNSCC) is still obscure. This study is aimed at exploring the prognostic and immunotherapeutic potential of SLC2A3 in HNSCC. Methods. All data were downloaded from TCGA database and integrated via R software. SLC2A3 expression was evaluated using R software, TIMER, CPTAC, and HPA databases. The association between SLC2A3 expression and clinicopathologic characteristics was assessed by R software. The effect of SLC2A3 on survival was analyzed by R software and Kaplan-Meier Plotter. Genomic alterations in SLC2A3 were investigated using the cBioPortal database. Coexpression of SLC2A3 was studied using LinkedOmics and STRING, and enrichment analyses were performed with R software. The relationship between SLC2A3 expression and immune infiltration was determined using TIMER and TISIDB databases. Immune checkpoints and ESTIMATE score were analyzed via the SangerBox database. Results. SLC2A3 expression was upregulated in HNSCC tissues compared to normal tissues. It was significantly related to TNM stage, histological grade, and alcohol history. High SLC2A3 expression was associated with poor prognosis in HNSCC. Coexpression analysis indicated that SLC2A3 mostly participated in the HIF-1 signaling pathway and glycolysis. Furthermore, SLC2A3 expression strongly correlated with tumor-infiltrating lymphocytes in HNSCC. Conclusion. SLC2A3 could serve as a potential prognostic biomarker for tumor immune infiltration in HNSCC.http://dx.doi.org/10.1155/2022/2371057
spellingShingle Manru Chu
Ke Zheng
Xiaojie Li
Zhiqiang Luo
Xin Yang
Changbo Wei
Comprehensive Analysis of the Role of SLC2A3 on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
Analytical Cellular Pathology
title Comprehensive Analysis of the Role of SLC2A3 on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
title_full Comprehensive Analysis of the Role of SLC2A3 on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
title_fullStr Comprehensive Analysis of the Role of SLC2A3 on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
title_full_unstemmed Comprehensive Analysis of the Role of SLC2A3 on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
title_short Comprehensive Analysis of the Role of SLC2A3 on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
title_sort comprehensive analysis of the role of slc2a3 on prognosis and immune infiltration in head and neck squamous cell carcinoma
url http://dx.doi.org/10.1155/2022/2371057
work_keys_str_mv AT manruchu comprehensiveanalysisoftheroleofslc2a3onprognosisandimmuneinfiltrationinheadandnecksquamouscellcarcinoma
AT kezheng comprehensiveanalysisoftheroleofslc2a3onprognosisandimmuneinfiltrationinheadandnecksquamouscellcarcinoma
AT xiaojieli comprehensiveanalysisoftheroleofslc2a3onprognosisandimmuneinfiltrationinheadandnecksquamouscellcarcinoma
AT zhiqiangluo comprehensiveanalysisoftheroleofslc2a3onprognosisandimmuneinfiltrationinheadandnecksquamouscellcarcinoma
AT xinyang comprehensiveanalysisoftheroleofslc2a3onprognosisandimmuneinfiltrationinheadandnecksquamouscellcarcinoma
AT changbowei comprehensiveanalysisoftheroleofslc2a3onprognosisandimmuneinfiltrationinheadandnecksquamouscellcarcinoma